{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Pfizer", "item": "https://www.patentleaderboard.com/2021/company/pfizer"}, {"@type": "ListItem", "position": 4, "name": "Robert Steven Kania", "item": "https://www.patentleaderboard.com/2021/inventor/fl:ro_ln:kania-3"}]}

Home › 2021 › Pfizer › Robert Steven Kania

Robert Steven Kania — 2 Patents in 2021

Pfizer: 2 patents #36 of 325Top 15%

Del Mar, CA: #27 of 95 inventorsTop 30%

California: #13,721 of 66,859 inventorsTop 25%

Overall (2021): #118,625 of 548,734Top 25%

2 Patents 2021

Issued Patents 2021

Showing 1–2 of 2 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
11203594	Anti-proliferative agents for treating PAH	Samit Kumar Bhattacharya, Douglas C. Behenna, Kimberly O. Cameron, Ping Chen, John M. Curto +10 more	2021-12-21	$2,121,061,000
11142525	Azalactam compounds as HPK1 inhibitors	Rebecca Anne Gallego, Sajiv Krishnan Nair, Omar Khaled Ahmad, Ted William Johnson, Jamison Bryce Tuttle +7 more	2021-10-12	$1,305,497,000

Robert Steven Kania — 2 Patents in 2021

Issued Patents 2021

Patent Widget